Moderna says its decision to remove a paediatric vaccine from Australia was due to stock shortages.
In comments emailed to The Epoch Times, Moderna Australia said that while the country’s pharmaceutical governing body, the Therapeutic Goods Administration, had provisionally approved the drug for use in children less than six years of age, the supply was exhausted.
